14:30 | Opening industrial exhibition |
15:30 | Multidisciplinary Management of Complex Disease |
15:30 | Welcome and introduction Michael Fischereder, Michael von Bergwelt, Ulrich Specks |
15:45 | ANCA-associated vasculitis: from pathogenesis to targeted therapy Ulrich Specks |
16:15 | Pulmonary hypertension associated with myeloproliferative and kidney disease Hilary M. DuBrock |
17:00 | Coffee break |
17:30 | Lung transplantation in patients with pulmonary hypertension Jürgen Behr |
18:00 | Immunotherapy of cancer – from bench to bedside Sebastian Kobold |
18:30 | Get together |
21:30 | End of day 1 |
08:00 | Opening industrial exhibition |
08:30 | Immunotherapy – from Vision to Standard of Care |
08:30 | Lung cancer therapy in the age of immunotherapy Tobias Peikert |
09:00 | Immune-checkpoint inhibitor therapy in renal cell carcinoma Michael Staehler |
09:30 | Immunotherapy for mesothelioma Tobias Peikert |
10:00 | Pathology of immune-checkpoint inhibitor therapy Mariam P. Alexander |
10:30 | ICU management of hemato-oncologic therapy complications Philippe R. Bauer |
11:00 | Coffee break |
11:30 | Novel Classification in Kidney Disease Impacts Management |
11:30 | Mapping the antigens of membranous nephropathy Sanjeev Sethi |
12:10 | Management of membranous nephropathy Fernando C. Fervenza |
12:40 | IgA nephropathy – same, same – or different? Jürgen Floege |
13:10 | Lunch |
14:10 | New Approaches in Complex and Rare Renal Disease |
14:10 | C3 Glomerulopathy: what is new? Sanjeev Sethi |
14:30 | Lupus nephritis – current and future treatment options Ali Duarte Garcia |
15:00 | Primary, secondary and genetic forms of FSGS: a clinical approace Fernando C. Fervenza |
15:30 | Coffee break |
16:00 | Dealing with Complications of Novel Therapy |
16:00 | Case Session |
16:30 | Renal pathology in monoclonal gammopathy Mariam P. Alexander |
17:00 | Critical care of immunocompromised patients Philippe R. Bauer |
17:30 | Avoiding collateral damage: precision immuno-therapy for autoimmunity and cancer Maximilian F. Konig |
18:00 | End of program |
19:00 | Congress Dinner (to be booked separately) |
08:30 | Opening industrial exhibition |
09:00 | Cellular Therapy Approaches |
09:00 | CAR-T cell therapy in hemato-oncology Marion Subklewe |
09:30 | CAR-T cell therapy for autoimmune disease Andreas Mackensen |
10:00 | Cell therapy in infectious disease Tobias Feuchtinger |
10:30 | Coffee break |
11:00 | From bench to bedside |
11:00 | Case Session |
11:30 | APS reclassified: understanding the new criteria and the clinical impact Ali Duarte Garcia |
12:00 | Antigen-specific therapies for anti-phospholipid syndrome Maximilian F. Konig |
12:30 | Wrap up and Farewell Michael Fischereder, Michael von Bergwelt, Ulrich Specks |
12:45 | Lunch |
13:45 | End of HONPlus Circle |
14:30 | Opening industrial exhibition |
15:30 | Multidisciplinary Management of Complex Disease |
15:30 | Welcome and introduction Michael Fischereder, Michael von Bergwelt, Ulrich Specks |
15:45 | ANCA-associated vasculitis: from pathogenesis to targeted therapy Ulrich Specks |
16:15 | Pulmonary hypertension associated with myeloproliferative and kidney disease Hilary M. DuBrock |
17:00 | Coffee break |
17:30 | Lung transplantation in patients with pulmonary hypertension Jürgen Behr |
18:00 | Immunotherapy of cancer – from bench to bedside Sebastian Kobold |
18:30 | Get together |
21:30 | End of day 1 |
08:00 | Opening industrial exhibition |
08:30 | Immunotherapy – from Vision to Standard of Care |
08:30 | Lung cancer therapy in the age of immunotherapy Tobias Peikert |
09:00 | Immune-checkpoint inhibitor therapy in renal cell carcinoma Michael Staehler |
09:30 | Immunotherapy for mesothelioma Tobias Peikert |
10:00 | Pathology of immune-checkpoint inhibitor therapy Mariam P. Alexander |
10:30 | ICU management of hemato-oncologic therapy complications Philippe R. Bauer |
11:00 | Coffee break |
11:30 | Novel Classification in Kidney Disease Impacts Management |
11:30 | Mapping the antigens of membranous nephropathy Sanjeev Sethi |
12:10 | Management of membranous nephropathy Fernando C. Fervenza |
12:40 | IgA nephropathy – same, same – or different? Jürgen Floege |
13:10 | Lunch |
14:10 | New Approaches in Complex and Rare Renal Disease |
14:10 | C3 Glomerulonephritis – the Mayo Clinic experience Sanjeev Sethi |
14:30 | Lupus nephritis – current and future treatment options Ali Duarte Garcia |
15:00 | Primary, secondary and genetic forms of FSGS: a clinical approace Fernando C. Fervenza |
15:30 | Coffee break |
16:00 | Dealing with Complications of Novel Therapy |
16:00 | Case Session |
16:30 | Renal pathology in monoclonal gammopathy Mariam P. Alexander |
17:00 | Critical care of immunocompromised patients Philippe R. Bauer |
17:30 | Avoiding collateral damage: precision immuno-therapy for autoimmunity and cancer Maximilian F. Konig |
18:00 | End of program |
19:00 | Congress Dinner (to be booked separately) |
08:30 | Opening industrial exhibition |
09:00 | Cellular Therapy Approaches |
09:00 | CAR-T cell therapy in hemato-oncology Marion Subklewe |
09:30 | CAR-T cell therapy for autoimmune disease Andreas Mackensen |
10:00 | Cell therapy in infectious disease Tobias Feuchtinger |
10:30 | Coffee break |
11:00 | From bench to bedside |
11:00 | Case Session |
11:30 | APS classification and impact Ali Duarte Garcia |
12:00 | Antigen-specific therapies for anti-phospholipid syndrome Maximilian F. Konig |
12:30 | Wrap up and Farewell Michael Fischereder, Michael von Bergwelt, Ulrich Specks |
12:45 | Lunch |
13:45 | End of HONPlus Circle |
14:30 | Opening industrial exhibition |
15:30 | Multidisciplinary Management of Complex Disease |
15:30 | Welcome and introduction Michael Fischereder, Michael von Bergwelt, Ulrich Specks |
15:45 | ANCA-associated vasculitis: from pathogenesis to targeted therapy Ulrich Specks |
16:15 | Pulmonary hypertension associated with myeloproliferative and kidney disease Hilary M. DuBrock |
17:00 | Coffee break |
17:30 | Lung transplantation in patients with pulmonary hypertension Jürgen Behr |
18:00 | Immunotherapy of cancer – from bench to bedside Sebastian Kobold |
18:30 | Get together |
21:30 | End of day 1 |
08:00 | Opening industrial exhibition |
08:30 | Immunotherapy – from Vision to Standard of Care |
08:30 | Lung cancer therapy in the age of immunotherapy Tobias Peikert |
09:00 | Immune-checkpoint inhibitor therapy in renal cell carcinoma Michael Staehler |
09:30 | Immunotherapy for mesothelioma Tobias Peikert |
10:00 | Pathology of immune-checkpoint inhibitor therapy Mariam P. Alexander |
10:30 | ICU management of hemato-oncologic therapy complications Philippe R. Bauer |
11:00 | Coffee break |
11:30 | Novel Classification in Kidney Disease Impacts Management |
11:30 | Mapping the antigens of membranous nephropathy Sanjeev Sethi |
12:10 | Management of membranous nephropathy Fernando C. Fervenza |
12:40 | IgA nephropathy – same, same – or different? Jürgen Floege |
13:10 | Lunch |
14:10 | New Approaches in Complex and Rare Renal Disease |
14:10 | C3 Glomerulonephritis – the Mayo Clinic experience Sanjeev Sethi |
14:30 | Lupus nephritis – current and future treatment options Ali Duarte Garcia |
15:00 | Primary, secondary and genetic forms of FSGS: a clinical approace Fernando C. Fervenza |
15:30 | Coffee break |
16:00 | Dealing with Complications of Novel Therapy |
16:00 | Case Session |
16:30 | Renal pathology in monoclonal gammopathy Mariam P. Alexander |
17:00 | Critical care of immunocompromised patients Philippe R. Bauer |
17:30 | Avoiding collateral damage: precision immuno-therapy for autoimmunity and cancer Maximilian F. Konig |
18:00 | End of program |
19:00 | Congress Dinner (to be booked separately) |
08:30 | Opening industrial exhibition |
09:00 | Cellular Therapy Approaches |
09:00 | CAR-T cell therapy in hemato-oncology Marion Subklewe |
09:30 | CAR-T cell therapy for autoimmune disease Andreas Mackensen |
10:00 | Cell therapy in infectious disease Tobias Feuchtinger |
10:30 | Coffee break |
11:00 | From bench to bedside |
11:00 | Case Session |
11:30 | APS reclassified: understanding the new criteria and the clinical impact Ali Duarte Garcia |
12:00 | Antigen-specific therapies for anti-phospholipid syndrome Maximilian F. Konig |
12:30 | Wrap up and Farewell Michael Fischereder, Michael von Bergwelt, Ulrich Specks |
12:45 | Lunch |
13:45 | End of HONPlus Circle |
14:30 | Opening industrial exhibition |
15:30 | Multidisciplinary Management of Complex Disease |
15:30 | Welcome and introduction Michael Fischereder, Michael von Bergwelt, Ulrich Specks |
15:45 | ANCA-associated vasculitis: from pathogenesis to targeted therapy Ulrich Specks |
16:15 | Pulmonary hypertension associated with myeloproliferative and kidney disease Hilary M. DuBrock |
17:00 | Coffee break |
17:30 | Lung transplantation in patients with pulmonary hypertension Jürgen Behr |
18:00 | Immunotherapy of cancer – from bench to bedside Sebastian Kobold |
18:30 | Get together |
21:30 | End of day 1 |
08:00 | Opening industrial exhibition |
08:30 | Immunotherapy – from Vision to Standard of Care |
08:30 | Lung cancer therapy in the age of immunotherapy Tobias Peikert |
09:00 | Immune-checkpoint inhibitor therapy in renal cell carcinoma Michael Staehler |
09:30 | Immunotherapy for mesothelioma Tobias Peikert |
10:00 | Pathology of immune-checkpoint inhibitor therapy Mariam P. Alexander |
10:30 | ICU management of hemato-oncologic therapy complications Philippe R. Bauer |
11:00 | Coffee break |
11:30 | Novel Classification in Kidney Disease Impacts Management |
11:30 | Mapping the antigens of membranous nephropathy Sanjeev Sethi |
12:10 | Management of membranous nephropathy Fernando C. Fervenza |
12:40 | IgA nephropathy – same, same – or different? Jürgen Floege |
13:10 | Lunch |
14:10 | New Approaches in Complex and Rare Renal Disease |
14:10 | C3 Glomerulopathy: what is new? Sanjeev Sethi |
14:30 | Lupus nephritis – current and future treatment options Ali Duarte Garcia |
15:00 | Primary, secondary and genetic forms of FSGS: a clinical approace Fernando C. Fervenza |
15:30 | Coffee break |
16:00 | Dealing with Complications of Novel Therapy |
16:00 | Case Session |
16:30 | Renal pathology in monoclonal gammopathy Mariam P. Alexander |
17:00 | Critical care of immunocompromised patients Philippe R. Bauer |
17:30 | Avoiding collateral damage: precision immuno-therapy for autoimmunity and cancer Maximilian F. Konig |
18:00 | End of program |
19:00 | Congress Dinner (to be booked separately) |
08:30 | Opening industrial exhibition |
09:00 | Cellular Therapy Approaches |
09:00 | CAR-T cell therapy in hemato-oncology Marion Subklewe |
09:30 | CAR-T cell therapy for autoimmune disease Andreas Mackensen |
10:00 | Cell therapy in infectious disease Tobias Feuchtinger |
10:30 | Coffee break |
11:00 | From bench to bedside |
11:00 | Case Session |
11:30 | APS classification and impact Ali Duarte Garcia |
12:00 | Antigen-specific therapies for anti-phospholipid syndrome Maximilian F. Konig |
12:30 | Wrap up and Farewell Michael Fischereder, Michael von Bergwelt, Ulrich Specks |
12:45 | Lunch |
13:45 | End of HONPlus Circle |